The real-world effectiveness and safety of vedolizumab for moderate-severe Crohn's disease: Results from the US VICTORY consortium

Parambir S. Dulai, Siddharth Singh, Xiaoqian Jiang, Farhad Peerani, Neeraj Narula, Khadija Chaudrey, Diana Whitehead, David Hudesman, Dana J. Lukin, Arun Swaminath, Eugenia Shmidt, Shuang Wang, Brigid S. Boland, John T. Chang, Sunanda Kane, Corey A. Siegel, Edward V. Loftus, William J. Sandborn, Bruce E. Sands, Jean Frederic Colombel

Research output: Contribution to journalArticle

143 Scopus citations

Fingerprint Dive into the research topics of 'The real-world effectiveness and safety of vedolizumab for moderate-severe Crohn's disease: Results from the US VICTORY consortium'. Together they form a unique fingerprint.

Medicine & Life Sciences